Pasar al contenido principal

NUEVA ESTRATEGIA FARMACOLOGICA FRENTE A PROTEINAS DIANA DEPENDIENTES DE ZINC: INHIBIDORES ALOSTERICOS DE LAS DEACETILASAS HDAC8 Y LPXC

PID2021-127296OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE ZARAGOZA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mass spectrometry footprinting reveals how kinetic stabilizers counteract transthyretin dynamics altered by pathogenic mutations

  • Garcia de Carvalho Pinheiro, Francisca|||0000-0003-3778-1528
  • Kant, Ravi|||0000-0002-0099-4346
  • Chemuru, Saketh
  • Varejão, Nathalia|||0000-0002-6952-8896
  • Velázquez-Campoy, Adrián|||0000-0001-5702-4538
  • Reverter Cendrós, David|||0000-0002-5347-0992
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Gross, Michael L.|||0000-0003-1159-4636
  • Ventura, Salvador|||0000-0002-9652-6351
The aggregation of transthyretin (TTR) results in life-threatening transthyretin amyloidosis. Familial forms of the disease arise from point mutations that destabilize the TTR tetramer, leading to its dissociation and/or monomer unfolding and subsequent formation of amyloid fibrils. Small molecules that kinetically stabilize the native tetramer effectively inhibit this aggregation. Although over 300 X-ray crystal structures of TTR have been determined, these data refer to a static structure and do not capture the conformational effects of mutations and ligand binding. Here, we demonstrate that hydrogen-deuterium exchange (HDX) and fast photochemical oxidation of proteins (FPOP) coupled with mass spectrometry (MS) offer critical insights into the conformational dynamics associated with TTR amyloidogenic mutations and the binding of kinetic stabilizers. The results indicate that the design of TTR binders should consider the specific conformational traits of each TTR pathogenic variant. We propose that incorporating MS-based techniques into TTR drug discovery will expedite the development of effective pathology-specific aggregation inhibitors.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 Mpro Main Protease Inhibitors

  • Peralta-Moreno, María Nuria
  • Antón-Muñoz, Vanessa
  • Ortega-Alarcón, David
  • Jiménez-Alesanco, Ana
  • Vega, Sonia
  • Abian, Olga
  • Velázquez-Campoy, Adrián
  • Thomson, Timothy M.
  • Granadino-Roldán, José Manuel
  • Machicado, Claudia
  • Rubio-Martínez, Jaime
Over 750 million cases of COVID-19, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), have been reported since the onset of the global outbreak. The need for effective treatments has spurred intensive research for therapeutic agents based on pharmaceutical repositioning or natural products. In light of prior studies asserting the bioactivity of natural compounds of the autochthonous Peruvian flora, the present study focuses on the identification SARS-CoV-2 Mpro main protease dimer inhibitors. To this end, a target-based virtual screening was performed over a representative set of Peruvian flora-derived natural compounds. The best poses obtained from the ensemble molecular docking process were selected. These structures were subjected to extensive molecular dynamics steps for the computation of binding free energies along the trajectory and evaluation of the stability of the complexes. The compounds exhibiting the best free energy behaviors were selected for in vitro testing, confirming the inhibitory activity of Hyperoside against Mpro, with a Ki value lower than 20 µM, presumably through allosteric modulation., This research was funded by The Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR)-Generalitat de Catalunya (2021SGR00350) and Spanish Structures and Excellence María de Maeztu program, grant number CEX2021-001202-M. Universitat de Barcelona PREDOCS-UB 2020 grant (5760700—Institut de Química Teòrica i Computacional to M.N.P.-M.), Fundación hna (to A.V.C. and O.A.), Fondo Investiga COVID-19 from Instituto de Investigación Sanitaria de Aragón IIS-A (to O.A. and A.V.-C.), Spanish Ministry of Economy and Competitiveness (BFU2016-78232-P to A.V.C., FPI predoctoral contract BES-2017-080739 to D.O.A.), Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033/and “ERDF A way of Making Europe” (PID2021-127296OB-I00 to A.V.C.), Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III and European Union (ERDF/ESF, “Investing in your future”) (PI18/00349 and PI21/00394 to O.A.), Diputación General de Aragón (Protein Targets and Bioactive Compounds Group E45_20R to A.V.C., Digestive Pathology Group B25_20R to O.A., and predoctoral contract 2019 to A.J.A.). Consejo Superior de Investigaciones Científicas (COV-006 and COV-201 to T.M.T.), Plataforma Temática Interdisciplinar Salud Global (PTI-SG + SGL2103019 to T.M.T.). Agència de Gestió d’Ajuts Universitaris i de Recerca (2020PANDE00048 to J.R.M and T.M.T.). Plan Nacional de I + D (PID-107139RB-C21 to T.M.T.)., With funding from the Spanish government through the ‘María de Maeztu Unit of Excelence’ accreditation (CEX2021-001202-M), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Unexpected thermodynamic signature for the interaction of hydroxymethylated DNA with MeCP2

  • Ortega-Alarcón, David
  • Claveria-Gimeno, Rafael
  • Vega, Sonia
  • Jorge-Torres, Olga C.
  • Esteller, Manel
  • Abian, Olga
  • Velázquez-Campoy, Adrián
Hydroxymethylated cytosine (5hmC) is a stable DNA epigenetic mark recognized by methyl-CpG binding protein 2 (MeCP2), which acts as a transcriptional regulator and a global chromatin-remodeling element. Because 5hmC triggers a gene regulation response markedly different from that produced by methylated cytosine (5mC), both modifications must affect DNA structure and/or DNA interaction with MeCP2 differently. MeCP2 is a six-domain intrinsically disordered protein (IDP) with two domains responsible for dsDNA binding: methyl-CpG binding domain (MBD) and intervening domain (ID). Here we report the detailed thermodynamic characterization of the interaction of hmCpG-DNA with MeCP2. We find that hmCpG-DNA interacts with MeCP2 in a distinctly different mode with a particular thermodynamic signature, compared to methylated or unmethylated DNA. In addition, we find evidence for Rett syndrome-associated mutations altering the interaction of MeCP2 with dsDNA in a cytosine modification-specific manner which may correlate with disease onset time and clinical severity score., This work was supported by the Spanish Ministry of Economy and Competitiveness and European ERDF Funds (MCIU/AEI/FEDER, EU) [BFU2016-78232-P to A.V.C., BES-2017-080739 to D.O.A.]; Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033/ and “ERDF A way of Making Europe” [PID2021-127296OB-I00 to A.V.C.]; Miguel Servet Program from Instituto de Salud Carlos III [CPII13/00017 to OA]; Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III and European Union (ERDF/ESF, “Investing in your future”) [PI18/00349 and PI21/00394 to O.A.]; Diputación General de Aragón [Protein Targets and Bioactive Compounds Group E45_20R to A.V.C., and Digestive Pathology Group B25_20R to O.A.]; and the Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

New insights into cancer: MDM2 binds to the citrullinating enzyme PADI4

  • Araujo-Abad, Salomé
  • Rizzuti, Bruno
  • Villamarin-Ortiz, Adrián
  • Pantoja-Uceda, D.
  • Moreno-Gonzalez, Celia M
  • Abian, Olga
  • Velázquez-Campoy, Adrián
  • Neira, José L.
  • de Juan Romero, Camino
20 pags., 8 figs., 1 tab., PADI4 is one of the human isoforms of a family of enzymes implicated in the conversion of arginine to citrulline. MDM2 is an E3 ubiquitin ligase which is crucial for down-regulation of degradation of the tumor suppressor gene p53. Given the relationship between both PADI4 and MDM2 with p53-signaling pathways, we hypothesized they may interact directly, and this interaction could be relevant in the context of cancer. Here, we showed their association in the nucleus and cytosol in several cancer cell lines. Furthermore, binding was hampered in the presence of GSK484, an enzymatic PADI4 inhibitor, suggesting that MDM2 could bind to the active site of PADI4, as confirmed by in silico experiments. In vitro and in silico studies showed that the isolated N-terminal region of MDM2, N-MDM2, interacted with PADI4, and residues Thr26, Val28, Phe91 and Lys98 were more affected by the presence of the enzyme. Moreover, the dissociation constant between N-MDM2 and PADI4 was comparable to the IC50 of GSK484 from in cellulo experiments. The interaction between MDM2 and PADI4 might imply MDM2 citrullination, with potential therapeutic relevance for improving cancer treatment, due to the generation of new antigens., This research was funded by Spanish Ministry of Economy and Competitiveness and European ERDF Funds(MCIU/AEI/FEDER, EU) [BFU2016-78232-P to AdrianVelazquez-Campoy]; by Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033/ and“ERDF Away of Making Europe”[PID2021-127296OB-I00 to Adrian Velazquez-Campoy]; by Instituto de Salud CarlosIII co-funded by European Social Fund“Investing in yourfuture”[CP19/00095 to Camino de Juan Romero][PI22/00824 to Camino de Juan Romero] [PI18/00394 toOlga Abian]; by Diputacion General de Aragon [“Proteintargets and Bioactive Compounds group”E45-20R toAdri an Velazquez-Campoy, and“Digestive PathologyGroup”B25-20R to Olga Abian], and by Consellería deInnovacion, Universidades, Ciencia y Sociedad Digital(Generalitat Valenciana) [CAICO 2021/0135 to Caminode Juan Romero and José L. Neira]. Salomé Araujo-Abadwas recipient of a“Carolina Foundation predoctoral fel-lowship 2020”. The funders had no role in the studydesign, data collection and analysis, decision to publish,or preparation of the manuscript.18 of 21ARAUJO-ABADET AL., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biological Calorimetry: Old Friend, New Insights

  • Abian, Olga
  • Vega, Sonia
  • Velázquez-Campoy, Adrián
Calorimetry is an old experimental technique (first instrument developed in S. XVIII), but it is broadly used and still provides key information for understanding biological processes at the molecular level, particularly, cooperative phenomena in protein interactions. Here, we review and highlight some key aspects of biological calorimetry. Several biological systems will be described in which calorimetry was instrumental for modeling the behavior of the protein and obtaining further biological insight., This work was supported by the Spanish Ministry of Economy and Competitiveness [BFU2016-78232-P to A.V.C.] and the Ministry of Science and Innovation MCIN/AEI/ 10.13039/501100011033/; “ERDF A way of Making Europe” [PID2021-127296OB-I00 to A.V.C.]; the Miguel Servet Program from Instituto de Salud Carlos III [CPII13/00017 to OA]; the Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III and the European Union (ERDF/ESF, “Investing in your future”) [PI18/00349 and PI21/00394 to O.A.]; the Diputación General de Aragón [Protein Targets and Bioactive Compounds Group E45_20R to A.V.C., and Digestive Pathology Group B25_20R to O.A.]; and the Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Unveiling the Binding between the Armadillo-Repeat Domain of Plakophilin 1 and the Intrinsically Disordered Transcriptional Repressor RYBP

  • Araujo-Abad, Salomé
  • Rizzuti, Bruno
  • Vidal, Miguel
  • Abian, Olga
  • Fárez-Vidal, María Esther
  • Velázquez-Campoy, Adrián
  • de Juan Romero, Camino
  • Neira, José L.
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)., Plakophilin 1 (PKP1), a member of the p120ctn subfamily of the armadillo (ARM)-repeat-containing proteins, is an important structural component of cell–cell adhesion scaffolds although it can also be ubiquitously found in the cytoplasm and the nucleus. RYBP (RING 1A and YY1 binding protein) is a multifunctional intrinsically disordered protein (IDP) best described as a transcriptional regulator. Both proteins are involved in the development and metastasis of several types of tumors. We studied the binding of the armadillo domain of PKP1 (ARM-PKP1) with RYBP by using in cellulo methods, namely immunofluorescence (IF) and proximity ligation assay (PLA), and in vitro biophysical techniques, namely fluorescence, far-ultraviolet (far-UV) circular dichroism (CD), and isothermal titration calorimetry (ITC). We also characterized the binding of the two proteins by using in silico experiments. Our results showed that there was binding in tumor and non-tumoral cell lines. Binding in vitro between the two proteins was also monitored and found to occur with a dissociation constant in the low micromolar range (~10 μM). Finally, in silico experiments provided additional information on the possible structure of the binding complex, especially on the binding ARM-PKP1 hot-spot. Our findings suggest that RYBP might be a rescuer of the high expression of PKP1 in tumors, where it could decrease the epithelial–mesenchymal transition in some cancer cells., This research was funded by the Spanish Ministry of Economy and Competitiveness and European ERDF Funds (MCIU/AEI/Feder, EU), grant numbers PID2021-127296OB-I00 to A.V.-C. and CP19/00095 to C.d.J.R.; Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III and European Union (ERDF/ESF, “Investing in your future”), grant numbers PI21/00394 to O.A. and PI22/00824 to C.d.J.R.; PAIDI program, Group BIO309; Junta de Andalucía and Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III, grant number PI10/00198, to M.E.F.-V.; Diputación General de Aragón, grant numbers E45-20R to A.V.-C. and B25-20R to O.A.; and Consellería de Innovación, Universidades, Ciencia y Sociedad Digital (Comunidad Valenciana), grant number CIAICO 2021/0135 to J.L.N. and C.d.J.R., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 Mpro Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation

  • Peralta-Moreno, María Nuria
  • Mena, Yago
  • Ortega-Alarcón, David
  • Jiménez-Alesanco, Ana
  • Vega, Sonia
  • Abian, Olga
  • Velázquez-Campoy, Adrián
  • Thomson, Timothy M.
  • Pinto, Marta
  • Granadino-Roldán, José Manuel
  • Santos Tomás, María
  • Pérez, Juan J.
  • Rubio-Martínez, Jaime
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)., The development of specific antiviral therapies targeting SARS-CoV-2 remains fundamental because of the continued high incidence of COVID-19 and limited accessibility to antivirals in some countries. In this context, dark chemical matter (DCM), a set of drug-like compounds with outstanding selectivity profiles that have never shown bioactivity despite being extensively assayed, appears to be an excellent starting point for drug development. Accordingly, in this study, we performed a high-throughput screening to identify inhibitors of the SARS-CoV-2 main protease (Mpro) using DCM compounds as ligands. Multiple receptors and two different docking scoring functions were employed to identify the best molecular docking poses. The selected structures were subjected to extensive conventional and Gaussian accelerated molecular dynamics. From the results, four compounds with the best molecular behavior and binding energy were selected for experimental testing, one of which presented inhibitory activity with a Ki value of 48 ± 5 μM. Through virtual screening, we identified a significant starting point for drug development, shedding new light on DCM compounds., This research was funded by The Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR)-Generalitat de Catalunya (2021SGR00350) and the Spanish Structures and Excellence María de Maeztu program, grant number CEX2021-001202-M; the Universitat de Barcelona PREDOCS-UB 2020 grant (5760700—Institut de Química Teòrica i Computacional to M.N.P.-M.); Fundación hna (to A.V.C. and O.A.); Fondo Investiga COVID-19 from Instituto de Investigación Sanitaria de Aragón IIS-A (to O.A. and A.V.-C.); the Spanish Ministry of Economy and Competitiveness (BFU2016-78232-P to A.V.C., FPI predoctoral contract BES-2017-080739 to D.O.A.); the Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033/ and “ERDF A way of Making Europe” (PID2021-127296OB-I00 to A.V.C.); the Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III and European Union (ERDF/ESF, “Investing in your future”) (PI18/00349 and PI21/00394 to O.A.); the Diputación General de Aragón (Protein Targets and Bioactive Compounds Group E45_23R to A.V.C., Digestive Pathology Group B25_23R to O.A., and predoctoral contract 2019 to A.J.A.); the Consejo Superior de Investigaciones Científicas (COV-006 and COV-201 to T.M.T.); the Plataforma Temática Interdisciplinar Salud Global (PTI-SG + SGL2103019 to T.M.T.); the Agència de Gestió d’Ajuts Universitaris i de Recerca (2020PANDE00048 to J.R.-M and T.M.T.); and the Plan Nacional de I + D (PID-107139RB-C21 to T.M.T.)., With funding from the Spanish government through the ‘María de Maeztu Unit of Excelence’ accreditation (CEX2021-001202-M)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Citrullinating enzyme PADI4 and transcriptional repressor RING1B bind in cancer cells

  • Araujo-Abad, Salomé
  • Rizzuti, Bruno
  • Soto-Conde, Lourdes
  • Vidal, Miguel
  • Abian, Olga
  • Velázquez-Campoy, Adrián
  • Neira, José L.
  • de Juan Romero, Camino
14 p.-8 fig., Polycomb groups (PcGs) are transcriptional repressors, formed by a complex of several proteins, involved in multicellular development and cancer epigenetics. One of these proteins is the E3 ubiquitin-protein ligase RING1 (or RING1B), associated with the regulation of transcriptional repression and responsible for monoubiquitylation of the histone H2A. On the other hand, PADI4 is one of the human isoforms of a family of enzymes implicated in the conversion of arginine to citrulline, and it is also involved in the development of glioblastoma, among other types of cancers. In this work, we showed the association of PADI4 and RING1B in the nucleus and cytosol in several cancer cell lines by using immunofluorescence and proximity ligation assays. Furthermore, we demonstrated that binding was hampered in the presence of GSK484, an enzymatic PADI4 inhibitor, suggesting that RING1B could bind to the active site of PADI4, as confirmed by protein-protein docking simulations. In vitro and in silico findings showed that binding to PADI4 occurred for the isolated fragments corresponding to both the N-terminal (residues 1–221) and C-terminal (residues 228–336) regions of RING1B. Binding to PADI4 was also hampered by GSK484, as shown by isothermal titration calorimetry (ITC) experiments for the sole N-terminal region, and by both NMR and ITC for the C-terminal one. The dissociation constants between PADI4 and any of the two isolated RING1B fragments were in the low micromolar range (~2–10 μM), as measured by fluorescence and ITC. The interaction between RING1B and PADI4 might imply citrullination of the former, leading to several biological consequences, as well as being of potential therapeutic relevance for improving cancer treatment with the generation of new antigens., This research was funded by Spanish Ministry of Economy and Competitiveness and European ERDF Funds (MCIU/AEI/FEDER, EU) [PID2021-127296OB-I00 to AVC, CP19/00095 to CdJ]; Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III, and European Union (ERDF/ESF, “Investing in your future”) [PI21/00394 to OA and PI22/00824 to CdJ]; Diputación General de Aragón [“Protein targets and Bioactive Compounds group” E45-23R to AVC, and “Digestive Pathology Group” B25-23R to OA]; and Comunidad Valenciana [CIAICO 2021/0135 to CdJ and JLN]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Serum-based detection of pancreatic and ovarian cancer via a nanoparticle-enhanced fluorescence array and machine learning

  • Morcuende-Ventura, Violeta
  • Sánchez-Gracia, Oscar
  • Abian-Franco, Natalia
  • Jiménez-Pardo, Isabel
  • Herrer, Lucía
  • Castillo-Vallés, Martín
  • Lancelot, Alexandre
  • Falcó-Martí, F. Javier
  • Hermoso-Durán, Sonia
  • Pazo-Cid, Roberto
  • Lanas, Ángel
  • Velázquez-Campoy, Adrián
  • Sierra, Teresa
  • Abian, Olga
[Background]: Early detection of oncological diseases such as pancreatic ductal adenocarcinoma (PDAC) and ovarian cancer (OV) is pivotal for successful treatment but remains a significant challenge due to the lack of sensitive and specific diagnostic tests. Fluorescence spectroscopy, enhanced by the interaction of serum proteins with nanoparticles (NPs) based on linear-dendritic block copolymers, has emerged as a promising technique for the noninvasive detection of these malignancies. This study introduces a novel array-based assay methodology to evaluate the diagnostic capabilities of various NPs within serum samples using fluorescence., [Methods]: We synthesized three types of NPs (1-SH, 2-OH, 3-NH3+) and analyzed their fluorescence spectra in serum samples from patients with PDAC, OV, and control subjects. The samples were excited at 330 and 350 nm wavelengths to obtain their fluorescence emission spectra. An array of machine learning algorithms was applied, including boosting and tree-based methods, to assess the ability of the spectral data to discriminate between pathological and nonpathological states. The algorithms' performance was measured by the area under the receiver operating characteristic curves (AUC)., [Results]: The fluorescence spectra revealed distinct patterns for PDAC and OV pathologies. 3-NH3+ NPs exhibited the highest differential capacity with AUCs exceeding 80% for PDAC across all algorithms, except one. 2-OH NPs showed a strong discriminatory ability for OV with AUCs over 70%, utilizing all but one of the algorithms. 1-SH NPs, however, did not significantly increase differentiability. Boosting algorithms generally outperformed other methods, indicating their suitability for this diagnostic approach., [Conclusions]: The proposed assay array methodology enables the systematic evaluation of NPs' diagnostic potential using fluorescence spectroscopy. The differential interactions between NPs and serum proteins specific to PDAC and OV highlight the method's capability to discern pathological states. These findings suggest a path forward for developing NP-assisted fluorescence spectroscopy as a viable tool for cancer diagnostics, potentially leading to earlier detection and improved patient outcomes., This research was funded by Ministerio de Ciencia e Innovación MCIN/AEI/10.13039/501100011033/and “ERDF A way of Making Europe” (PID2021–127296OB-I00 to A.V.C., PID2021–126132NB-I00 to T.S., and the INMA Severo Ochoa Excellence Center CEX2023–001286-S grant); Instituto de Salud Carlos III and cofunded by European Union (ESF, ”Investing in your future”) (PI18/00349, and PI21/00394 PFIS grants to O.A.; FI19/00146 PFIS contract to S.H.-D.); Gobierno de Aragón (PROY_B08_24, Protein Targets and Bioactive Compounds Group E45_23R to A.V.C., Digestive Pathology Group B25_23R to O.A., and Liquid Crystals and Polymers Group, E47_23R); and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd)., We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Buttressing ligand-binding pockets in de novo designed NTF2-like domains

  • Nadal, Marta
  • Albi-Puig, Joana
  • Castellví, Albert
  • Garcia-Franco, Paula M.
  • Vega, Sonia
  • Velázquez-Campoy, Adrián
  • Marcos, Enrique
NTF2-like proteins are compact α + β fold domains with cone-shaped architectures and internal pockets, making them attractive scaffolds for the de novo design of small-molecule binders and enzymes. However, creating ligand-binding pockets often compromises folding stability, posing a key challenge in de novo protein design. Here, we introduce strategies to stabilize NTF2-like domains while preserving pocket geometry and accessibility. By expanding the hydrophobic core through computationally designed α-helical subdomains or homodimer interfaces buttressing the β-sheet's convex face, we enhance structural stability without blocking pocket access on the concave face. Biochemical, biophysical, and crystallographic analyses confirm that the designed buttressing elements maintain the intended fold and support diverse, well-formed hydrophobic ligand-binding pockets with increased preorganization. Our results demonstrate that structural stabilization and pocket optimization need not be mutually exclusive, providing a generalizable approach to create robust ligand-binding proteins. This framework addresses a major bottleneck in protein design and should fuel the development of NTF2-based scaffolds for applications in small-molecule biosensing and enzyme catalysis., This research was supported by grants from the Spanish Ministry of Science and Innovation (RYC2018-025295-I, EUR2020-112164, CNS2023-144990) and AGAUR (2021SGR00423) to E.M. J.A-P. was supported by a FPU predoctoral fellowship (under grant agreement FPU23/01041). A.C. was supported by STFC-UK/CCP4 “Agreement for the integration of methods into the CCP4 software distribution, ARCIMBOLDO_LOW”. This work was supported by the Ministerio de Ciencia e Innovación (MCIN/AEI/10.13039/501100011033/) and “ERDF A way of Making Europe” (PID2021-127296OB-I00) to A.V.C., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Biological Calorimetry: Old Friend, New Insights

  • Abian, Olga
  • Vega, Sonia
  • Velazquez-Campoy, Adrian
Calorimetry is an old experimental technique (first instrument developed in S. XVIII), but it is broadly used and still provides key information for understanding biological processes at the molecular level, particularly, cooperative phenomena in protein interactions. Here, we review and highlight some key aspects of biological calorimetry. Several biological systems will be described in which calorimetry was instrumental for modeling the behavior of the protein and obtaining further biological insight.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Citrullination at the N-terminal region of <scp>MDM2</scp> by the <scp>PADI4</scp> enzyme

  • Neira, José L.
  • Rizzuti, Bruno
  • Palomino-Schätzlein, Martina
  • Rejas, Virginia
  • Abian, Olga
  • Velazquez-Campoy, Adrian
PADI4 is one of the human isoforms of a family of enzymes involved in the conversion of arginine to citrulline. MDM2 is an E3 ubiquitin ligase that is critical for degradation of the tumor suppressor gene p53. We have previously shown that there is an interaction between MDM2 and PADI4 in cellulo, and that such interaction occurs through the N‐terminal region of MDM2, N‐MDM2, and in particular through residues Thr26, Val28, Phe91, and Lys98. Here, by using a “divide‐and‐conquer” approach, we have designed and synthesized peptides comprising these two polypeptide stretches (residues Ala21–Lys36, and Lys94–Val108), either in the wild‐type species or in their citrullinated versions. Some of the citrullinated peptides were aggregation‐prone, as suggested by DOSY‐NMR experiments, but the wild‐type versions of both fragments were monomeric in solution. We found out that wild‐type and modified peptides were disordered in all cases, as also tested by far‐UV circular dichroism (CD), and citrullination mainly affected the NMR chemical shifts of adjacent residues. Isothermal titration calorimetry (ITC) in the absence and presence of GSK484, an enzymatic PADI4 inhibitor, indicated that this compound blocked binding of the peptides to the enzyme. Binding to the active site of the N‐MDM2 fragments was also confirmed by in silico experiments. The affinities of PADI4 for the wild‐type peptides were more favorable than those of the corresponding citrullinated ones, but all measured values were within the micromolar range, indicating that there were no major variations in the thermodynamics of binding due to sequence effects. The kinetic dissociation rates, koff, measured by biolayer interferometry (BLI), were always one‐order of magnitude faster for the citrullinated peptides than for the wild‐type ones. Taken together, all these findings indicate that MDM2 is a substrate for PADI4 and is prone to citrullination in the identified (and specific) positions of its N‐terminal region.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Serum-Based Detection of Pancreatic and Ovarian Cancer via a Nanoparticle-Enhanced Fluorescence Array and Machine Learning

  • Morcuende-Ventura, Violeta
  • Sánchez-Gracia, Oscar
  • Abian-Franco, Natalia
  • Jiménez-Pardo, Isabel
  • Herrer, Lucía
  • Castillo-Vallés, Martín
  • Lancelot, Alexandre
  • Falcó-Martí, F. Javier
  • Hermoso-Durán, Sonia
  • Pazo-Cid, Roberto
  • Lanas, Ángel
  • Velazquez-Campoy, Adrián
  • Sierra, Teresa
  • Abian, Olga
Early detection of oncological diseases such as pancreatic ductal adenocarcinoma (PDAC) and ovarian cancer (OV) is pivotal for successful treatment but remains a significant challenge due to the lack of sensitive and specific diagnostic tests. Fluorescence spectroscopy, enhanced by the interaction of serum proteins with nanoparticles (NPs) based on linear–dendritic block copolymers, has emerged as a promising technique for the noninvasive detection of these malignancies. This study introduces a novel array-based assay methodology to evaluate the diagnostic capabilities of various NPs within serum samples using fluorescence. Methods: We synthesized three types of NPs (1-SH, 2-OH, 3-NH3+) and analyzed their fluorescence spectra in serum samples from patients with PDAC, OV, and control subjects. The samples were excited at 330 and 350 nm wavelengths to obtain their fluorescence emission spectra. An array of machine learning algorithms was applied, including boosting and tree-based methods, to assess the ability of the spectral data to discriminate between pathological and nonpathological states. The algorithms’ performance was measured by the area under the receiver operating characteristic curves (AUC). Results: The fluorescence spectra revealed distinct patterns for PDAC and OV pathologies. 3-NH3+ NPs exhibited the highest differential capacity with AUCs exceeding 80% for PDAC across all algorithms, except one. 2-OH NPs showed a strong discriminatory ability for OV with AUCs over 70%, utilizing all but one of the algorithms. 1-SH NPs, however, did not significantly increase differentiability. Boosting algorithms generally outperformed other methods, indicating their suitability for this diagnostic approach. Conclusions: The proposed assay array methodology enables the systematic evaluation of NPs’ diagnostic potential using fluorescence spectroscopy. The differential interactions between NPs and serum proteins specific to PDAC and OV highlight the method’s capability to discern pathological states. These findings suggest a path forward for developing NP-assisted fluorescence spectroscopy as a viable tool for cancer diagnostics, potentially leading to earlier detection and improved patient outcomes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Modulation of conformational features and oligomerization of MMACHC by cobalamin variants: impact of the R161Q mutation in cblC disease

  • Longo, Lisa
  • Costa, Maria Assunta
  • Carrotta, Rita
  • Mangione, Maria Rosalia
  • Martorana, Vincenzo
  • Tutone, Marco
  • Ortore, Maria Grazia
  • Garcia-Franco, Paula M.
  • Vega, Sonia
  • Velazquez-Campoy, Adrian
  • Passantino, Rosa
  • Vilasi, Silvia
Vitamin B12 (cobalamin, Cbl) is a coordination compound of the cobalt, located at the center of a corrin ring composed of four pyrrolic-like groups. The cobalt ion can be bound to a variety of upper axial ligands, which vary among different cobalamin forms, including hydroxocobalamin (OHCbl), cyanocobalamin (CNCbl), methylcobalamin (MeCbl), and adenosylcobalamin (AdoCbl). MeCbl and AdoCbl are considered the biologically active forms, serving as cofactors in the metabolism of methylmalonic acid (MMA) and homocysteine (HCY). Impaired conversion of these metabolites leads to their pathological accumulation, resulting in severe cellular damage. This is precisely what occurs in cblC deficiency, a rare inborn disorder caused by mutations in the MMACHC protein, which plays a crucial role in binding and processing the various cobalamin forms. Mutations affecting MMACHC function impair its ability to correctly handle cobalamins, leading to the disease. In this study, we evaluated the impact of various cobalamin forms, specifically AdoCbl, MeCbl, and CNCbl, on the stability and oligomeric organization of the wild type MMACHC protein, using circular dichroism spectroscopy, native gel electrophoresis, and small-angle X-ray scattering. Moreover, isothermal titration calorimetry experiments provided insights into the thermodynamic parameters governing MMACHC binding to these cobalamins. In addition, we also assessed how the R161Q mutation in MMACHC alters the affinity of this protein for the different vitamin B12 forms, leading to decreased stability and impaired homodimerization, a process likely relevant to its functional role. Our findings provide molecular insights into cblC pathogenesis and advance our understanding of MMACHC structure–function relationships.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Repurposing Drugs as Bacteroides fragilis BFT-3 Inhibitors in the Animal Infection Model Galleria mellonella

  • Jiménez-Alesanco, Ana
  • Gómara-Lomero, Marta
  • Jeblaoui, Hajar
  • Vega, Sonia
  • Velázquez-Campoy, Adrián
  • Aínsa, José Antonio
  • Abián, Olga
Bacteroides fragilis is a key component of the human gut microbiota, although enterotoxigenic strains (ETBF), which produce B. fragilis toxin (BFT), can act as opportunistic pathogens. BFT disrupts intestinal epithelial integrity and contributes to conditions such as inflammatory bowel disease and colorectal cancer. This study aimed to characterize three allosteric inhibitors of BFT-3 (isoform 3 of BFT), previously identified by our group through high-throughput screening of US Food and Drug Administration approved drugs. We evaluated their activities in vitro and in vivo. Using Galleria mellonella larvae as a novel infection model for B. fragilis, we assessed the antimicrobial and antivirulence potential of these compounds. Among the three tested compounds, MOA4 demonstrated superior efficacy, enhanced bacterial clearance in vivo, and increased larval survival in a dose-dependent manner, with minimal toxicity. Synergy studies have revealed the potential combinatory effects of MOA4 and conventional antibiotics. These findings establish G. mellonella as a valuable alternative model for studying B. fragilis infections and highlight MOA4 as a promising candidate to be repurposed for the treatment of B. fragilis-mediated diseases while preserving commensal microbiota.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Citrullination at the Nuclear Localization Signal of the Inhibitor of Growth 4 (ING4) Interferes With its Binding to Importin α3

  • Álvarez-Rodríguez, María Gabriela
  • Vega, Sonia
  • Hornos, Felipe
  • Fienco-Bacusoy, Augusto
  • Abian, Olga
  • Velazquez-Campoy, Adrian
  • Rizzuti, Bruno
  • Neira, José L.
The inhibitor of growth 4 (ING4) acts as a tumor suppressor regulating chromatin structure. Due to this nuclear function, ING4 has a nuclear localization signal (NLS), which is recognized by the cellular translocation machinery ‒ mainly formed by proteins named importins, which include the isoform importin α3 (Impα3) ‒ to allow movement through the nuclear membrane. Peptidyl arginine iminohydrolases (PADIs) are enzymes involved in the posttranslational modification of arginine to citrulline. PADI4, one of the five isoforms of PADI in humans, citrullinates ING4 at the NLS region. We studied in vitro and in silico how the different degrees of citrullination affected binding of the NLS of ING4 to PADI4, Impα3 and its truncated species (ΔImpα3), lacking the importin binding domain, by using several biophysical techniques and molecular simulations. To that end, we synthesized eight peptides encompassing the NLS of ING4 (residues 130–152), with single, double and triple citrulline replacements at Arg132, Arg142 and Arg144. The peptides were monomeric and disordered, as tested by DOSY, 1D- and 2D-1H NMR experiments. All the peptides were capable of binding to PADI4 with low micromolar affinities, but their affinity decreased as the fraction of citrullination increased. Moreover, all peptides could bind to both importin species with affinities in the low micromolar range, and their affinities were also dependent on the citrullination degree. The peptides targeted the canonical NLS binding site for cargo proteins of both importin species. These findings suggest that: (i) citrullination at the NLS might interfere with ING4 nuclear translocation; and (ii) successive citrullination at the NLS affected binding to PADI4.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Extending MeCP2 interactome, canonical nucleosomal histones interact with MeCP2

  • Ortega-Alarcon, David|||0000-0003-1885-4365
  • Claveria-Gimeno, Rafael
  • Vega, Sonia
  • Kalani, Ladan|||0000-0002-0892-3745
  • Jorge-Torres, Olga Caridad|||0000-0002-1219-8865
  • Esteller, M.|||0000-0003-4490-6093
  • Ausio, Juan
  • Abián, Olga|||0000-0001-5664-1729
  • Velázquez-Campoy, Adrián|||0000-0001-5702-4538
MeCP2 is a general regulator of transcription involved in the repression/activation of genes depending on the local epigenetic context. It acts as a chromatin regulator and binds with exquisite specificity to gene promoters. The set of epigenetic marks recognized by MeCP2 has been already established (mainly, cytosine modifications in CpG and CpA), as well as many of the constituents of its interactome. We unveil a new set of interactions for MeCP2 with the four canonical nucleosomal histones. MeCP2 interacts with high affinity with H2A, H2B, H3 and H4. In addition, Rett syndrome associated mutations in MeCP2 and histone epigenetic marks modulate these interactions. Given the abundance and the structural/functional relevance of histones and their involvement in epigenetic regulation, this new set of interactions and its modulating elements provide a new addition to the 'alphabet' for this epigenetic reader.